| 18th Jun 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 17th Jun 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 16th Jun 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 13th Jun 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 13th Jun 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 13th Jun 2025 7:00 am |
RNS |
GSK submits Arexvy for adults 18+ with EMA |
| 12th Jun 2025 11:00 am |
PRN |
Director/PDMR Shareholding |
| 12th Jun 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 11th Jun 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 11th Jun 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 10th Jun 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 9th Jun 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 6th Jun 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 5th Jun 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 4th Jun 2025 7:00 am |
RNS |
GSK - second tranche of share buyback programme |
| 4th Jun 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 3rd Jun 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 2nd Jun 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 2nd Jun 2025 3:00 pm |
RNS |
Total Voting Rights |
| 2nd Jun 2025 7:00 am |
RNS |
Linerixibat file accepted for review by US FDA |
| 2nd Jun 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 30th May 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 29th May 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 28th May 2025 12:00 pm |
RNS |
GSK stops Phase 3 trial on cUTIs for efficacy |
| 28th May 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 27th May 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 23rd May 2025 12:16 pm |
RNS |
positive CHMP opinion on Blenrep in EU |
| 23rd May 2025 7:00 am |
RNS |
FDA approves Nucala COPD indication |
| 23rd May 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 22nd May 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 21st May 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 20th May 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 20th May 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 19th May 2025 7:00 am |
RNS |
Blenrep for 2L+ multiple myeloma approved in Japan |
| 19th May 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 16th May 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 15th May 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 14th May 2025 7:00 am |
RNS |
GSK to acquire efimosfermin |
| 14th May 2025 7:00 am |
RNS |
Transaction in Own Shares |
| 13th May 2025 3:30 pm |
RNS |
Director/PDMR Shareholding |
